Recent Updates
Recently added Catalysts
BCAX Positive Sentiment

Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

Monday, November 11, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, will present at the Stifel 2024 Healthcare Conference in New York on November 19, 2024. The CEO, Claire Mazumdar, is expected to lead the presentation, highlighting the company's work on bifunctional therapies for solid tumors. A live webcast will be available on their website, with an archived version accessible for 90 days post-event.
Price reaction · baseline $23.82 (2024-11-08 close) · 1 other BCAX headline(s) in the window, move may be shared
day 0 close · peak
+1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bicara Therapeutics is presenting at a major healthcare conference, showcasing their advancements.
  • The CEO's involvement highlights the importance of the event for the company's visibility.
  • The webcast allows for broader accessibility to their presentation, potentially attracting interest.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+36%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Ficerafusp alfa
Phase 2 · Squamous Cell Carcinoma of Head and Neck (SCCHN)

Full Press Release Details

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer of Bicara Therapeutics, will present at the Stifel 2024 Healthcare Conference in New York, NY on Tuesday, November 19, 2024 at 9:10 a.m. ET.
A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for approximately 90 days following the presentation.
About Bicara Therapeutics

Frequently Asked Questions

When will Bicara Therapeutics present at the Stifel Conference?

Bicara Therapeutics will present on November 19, 2024, at 9:10 a.m. ET.

How can I watch the Bicara presentation live?

The presentation can be streamed live on Bicara's website.

Is there a replay available for the Bicara presentation?

Yes, an archived replay will be available for about 90 days post-presentation.

Who is presenting for Bicara Therapeutics?

Claire Mazumdar, PhD, MBA, will represent Bicara Therapeutics.

What is the focus of Bicara Therapeutics?

Bicara Therapeutics develops bifunctional therapies for solid tumors.

ShareAdd on Google
Tags: BCAX Viatris Investor Conferences Healthcare Bicara Therapeutics Stifel 2024 healthcare conference bifunctional therapies
Last updated: Nov 11, 2024

Biotech snapshot

Cash runway
$497M liquidity · $15M/mo burn
~33 mo
Minimal dilution risk
Lead asset
Ficerafusp alfaPhase 2
Squamous Cell Carcinoma of Head and Neck (SCCHN) →

Catalyst track record

+36%
best trade around BCAX's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for BCAX.

See every catalyst's timing & PoA →